PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
Clinical trial NCT03507374 · TERMINATED
Trial details
- NCT number
- NCT03507374
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2020-04-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.